Jt Stratford LLC Abb Vie Inc. Transaction History

Jt Stratford LLC

$568 Million
Q3 2024

A detailed history of Jt Stratford LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Jt Stratford LLC holds 7,107 shares of ABBV stock, worth $1.21 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

7,107

Previous 6,571 8.16%

Holding current value

$1.21 Million

Previous $1.13 Million 24.49%

% of portfolio

0.25%

Previous 0.22%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $87,818 - $106,840	536 Added 8.16%	7,107 $1.4 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $42,722 - $49,889	276 Added 4.38%	6,571 $1.13 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $8,790 - $10,015	55 Added 0.88%	6,295 $1.15 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $505,817 - $569,669	-3,676 Reduced 37.07%	6,240 $967,000
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $209,869 - $242,955	1,571 Added 18.83%	9,916 $1.48 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $56,846 - $70,742	429 Added 5.42%	8,345 $1.12 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $165,433 - $190,521	1,144 Added 16.89%	7,916 $1.26 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $21,161 - $25,378	153 Added 2.31%	6,772 $1.1 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $69,654 - $79,889	-519 Reduced 7.27%	6,619 $888,000
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $318,177 - $404,507	-2,312 Reduced 24.47%	7,138 $1.09 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $105,715 - $131,163	-801 Reduced 7.81%	9,450 $1.53 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $16,007 - $20,253	-149 Reduced 1.43%	10,251 $1.39 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $5,213 - $5,918	-49 Reduced 0.47%	10,400 $1.12 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $60,285 - $67,161	573 Added 5.8%	10,449 $1.18 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $121,225 - $133,454	1,185 Added 13.63%	9,876 $1.07 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $3,702 - $4,998	-46 Reduced 0.53%	8,691 $931,000
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $124,999 - $146,707	-1,455 Reduced 14.28%	8,737 $765,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $120,326 - $161,015	1,640 Added 19.18%	10,192 $1 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $192,726 - $292,196	2,988 Added 53.7%	8,552 $652,000
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $65,854 - $82,398	-913 Reduced 14.1%	5,564 $493,000
Q3 2019 Nov 19, 2019	BUY	$62.98 - $75.72 $97,493 - $117,214	1,548 Added 31.41%	6,477 $490,000
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $15,242 - $19,483	-232 Reduced 4.5%	4,929 $358,000
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $137,772 - $162,150	-1,786 Reduced 25.71%	5,161 $416,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $45,542 - $56,165	-585 Reduced 7.77%	6,947 $640,000
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $28,717 - $31,925	-323 Reduced 4.11%	7,532 $712,000
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $75,325 - $89,126	839 Added 11.96%	7,855 $728,000
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $40,484 - $54,212	440 Added 6.69%	7,016 $664,000
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $58,214 - $63,836	650 Added 10.97%	6,576 $636,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $413,931 - $528,717	5,926	5,926 $527,000

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jt Stratford LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jt Stratford LLC with notifications on news.

Account